Ondansetron
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Ondansetron
Ondansetron
Summary
The TxGNN model has no candidate with a score of 0.99 or higher for Ondansetron, so there is currently no new predicted indication. The drug’s recorded uses are listed below. They are the drug’s own recorded uses, not model candidates.
Quick overview
| Item | Content |
|---|---|
| Known uses recorded for this drug | 2 |
| Australia Market Status | Listed on the PBS Schedule (1 of 1 items) – TGA (ARTG) registration status is not included in this data |
| Number of PBS Items | 1 (valid: 1) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| nausea | licence in another country |
| vomiting | licence in another country |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| none |
Australia Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 1594X | Zofran | Tablet 4 mg (as hydrochloride dihydrate) | Valid |
Safety Considerations
- Disease associations from the knowledge graph (not label text): long QT syndrome, familial long QT syndrome, torsades de pointes, liver failure, epilepsy, basal ganglia disease, focal hand dystonia and blepharospasm. These should be verified against the Product Information.
- Drug interactions (DDInter, 100 reported; examples shown):
- Major: fentanyl, alfentanil, tramadol, dextromethorphan, almotriptan, sumatriptan, amiodarone, amisulpride, amitriptyline, anagrelide. Many involve QT prolongation or serotonin syndrome risk.
- Moderate: abametapir, abiraterone, dihydrocodeine, codeine, famotidine, formoterol, adenosine, salbutamol, alfuzosin, celecoxib.
Please refer to the TGA-approved Product Information (PI) for full warnings and contraindications.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.